These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1333 related articles for article (PubMed ID: 28467028)

  • 1. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.
    Höglinger GU; Respondek G; Stamelou M; Kurz C; Josephs KA; Lang AE; Mollenhauer B; Müller U; Nilsson C; Whitwell JL; Arzberger T; Englund E; Gelpi E; Giese A; Irwin DJ; Meissner WG; Pantelyat A; Rajput A; van Swieten JC; Troakes C; Antonini A; Bhatia KP; Bordelon Y; Compta Y; Corvol JC; Colosimo C; Dickson DW; Dodel R; Ferguson L; Grossman M; Kassubek J; Krismer F; Levin J; Lorenzl S; Morris HR; Nestor P; Oertel WH; Poewe W; Rabinovici G; Rowe JB; Schellenberg GD; Seppi K; van Eimeren T; Wenning GK; Boxer AL; Golbe LI; Litvan I;
    Mov Disord; 2017 Jun; 32(6):853-864. PubMed ID: 28467028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which ante mortem clinical features predict progressive supranuclear palsy pathology?
    Respondek G; Kurz C; Arzberger T; Compta Y; Englund E; Ferguson LW; Gelpi E; Giese A; Irwin DJ; Meissner WG; Nilsson C; Pantelyat A; Rajput A; van Swieten JC; Troakes C; Josephs KA; Lang AE; Mollenhauer B; Müller U; Whitwell JL; Antonini A; Bhatia KP; Bordelon Y; Corvol JC; Colosimo C; Dodel R; Grossman M; Kassubek J; Krismer F; Levin J; Lorenzl S; Morris H; Nestor P; Oertel WH; Rabinovici GD; Rowe JB; van Eimeren T; Wenning GK; Boxer A; Golbe LI; Litvan I; Stamelou M; Höglinger GU;
    Mov Disord; 2017 Jul; 32(7):995-1005. PubMed ID: 28500752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.
    Ali F; Martin PR; Botha H; Ahlskog JE; Bower JH; Masumoto JY; Maraganore D; Hassan A; Eggers S; Boeve BF; Knopman DS; Drubach D; Petersen RC; Dunkley ED; van Gerpen J; Uitti R; Whitwell JL; Dickson DW; Josephs KA
    Mov Disord; 2019 Aug; 34(8):1144-1153. PubMed ID: 30726566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy.
    Respondek G; Roeber S; Kretzschmar H; Troakes C; Al-Sarraj S; Gelpi E; Gaig C; Chiu WZ; van Swieten JC; Oertel WH; Höglinger GU
    Mov Disord; 2013 Apr; 28(4):504-9. PubMed ID: 23436751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.
    Litvan I; Agid Y; Calne D; Campbell G; Dubois B; Duvoisin RC; Goetz CG; Golbe LI; Grafman J; Growdon JH; Hallett M; Jankovic J; Quinn NP; Tolosa E; Zee DS
    Neurology; 1996 Jul; 47(1):1-9. PubMed ID: 8710059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability.
    Kurz C; Ebersbach G; Respondek G; Giese A; Arzberger T; Höglinger GU
    Acta Neuropathol Commun; 2016 Nov; 4(1):120. PubMed ID: 27842578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
    Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
    BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?
    Shoeibi A; Litvan I; Juncos JL; Bordelon Y; Riley D; Standaert D; Reich SG; Shprecher D; Hall D; Marras C; Kluger B; Olfati N; Jankovic J
    Parkinsonism Relat Disord; 2019 Dec; 69():34-39. PubMed ID: 31665686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Conditions "Suggestive of Progressive Supranuclear Palsy"-Diagnostic Performance.
    Grimm MJ; Respondek G; Stamelou M; Arzberger T; Ferguson L; Gelpi E; Giese A; Grossman M; Irwin DJ; Pantelyat A; Rajput A; Roeber S; van Swieten JC; Troakes C; Meissner WG; Nilsson C; Piot I; Compta Y; Rowe JB; Höglinger GU;
    Mov Disord; 2020 Dec; 35(12):2301-2313. PubMed ID: 32914550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive supranuclear palsy.
    Giagkou N; Höglinger GU; Stamelou M
    Int Rev Neurobiol; 2019; 149():49-86. PubMed ID: 31779824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?
    Whitwell JL; Höglinger GU; Antonini A; Bordelon Y; Boxer AL; Colosimo C; van Eimeren T; Golbe LI; Kassubek J; Kurz C; Litvan I; Pantelyat A; Rabinovici G; Respondek G; Rominger A; Rowe JB; Stamelou M; Josephs KA;
    Mov Disord; 2017 Jul; 32(7):955-971. PubMed ID: 28500751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Video-tutorial for the Movement Disorder Society criteria for progressive supranuclear palsy.
    Iankova V; Respondek G; Saranza G; Painous C; Cámara A; Compta Y; Aiba I; Balint B; Giagkou N; Josephs KA; Otsuki M; Golbe LI; Bhatia KP; Stamelou M; Lang AE; Höglinger GU;
    Parkinsonism Relat Disord; 2020 Sep; 78():200-203. PubMed ID: 32988736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor, cognitive and behavioral differences in MDS PSP phenotypes.
    Picillo M; Cuoco S; Tepedino MF; Cappiello A; Volpe G; Erro R; Santangelo G; Pellecchia MT; Barone P;
    J Neurol; 2019 Jul; 266(7):1727-1735. PubMed ID: 30989369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive Supranuclear Palsy: an Update.
    Armstrong MJ
    Curr Neurol Neurosci Rep; 2018 Feb; 18(3):12. PubMed ID: 29455271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy.
    Grimm MJ; Respondek G; Stamelou M; Arzberger T; Ferguson L; Gelpi E; Giese A; Grossman M; Irwin DJ; Pantelyat A; Rajput A; Roeber S; van Swieten JC; Troakes C; Antonini A; Bhatia KP; Colosimo C; van Eimeren T; Kassubek J; Levin J; Meissner WG; Nilsson C; Oertel WH; Piot I; Poewe W; Wenning GK; Boxer A; Golbe LI; Josephs KA; Litvan I; Morris HR; Whitwell JL; Compta Y; Corvol JC; Lang AE; Rowe JB; Höglinger GU;
    Mov Disord; 2019 Aug; 34(8):1228-1232. PubMed ID: 30884545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
    Williams DR; de Silva R; Paviour DC; Pittman A; Watt HC; Kilford L; Holton JL; Revesz T; Lees AJ
    Brain; 2005 Jun; 128(Pt 6):1247-58. PubMed ID: 15788542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive supranuclear palsy.
    Esper CD; Weiner WJ; Factor SA
    Rev Neurol Dis; 2007; 4(4):209-16. PubMed ID: 18195676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of PSP phenotypes with survival: A brain-bank study.
    Guasp M; Molina-Porcel L; Painous C; Caballol N; Camara A; Perez-Soriano A; Sánchez-Gómez A; Garrido A; Muñoz E; Marti MJ; Valldeoriola F; Grau O; Gelpí E; Respondek G; Höglinger GH; Compta Y
    Parkinsonism Relat Disord; 2021 Mar; 84():77-81. PubMed ID: 33581485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are PSP patients included in clinical trials representative of the general PSP population?
    Mariani LL; Guimarães-Costa R; Grabli D; Le Toullec B; Cormier-Dequaire F; Degos B; Dubois B; Vidailhet M; Lacomblez L; Corvol JC
    Parkinsonism Relat Disord; 2019 Sep; 66():202-206. PubMed ID: 31303434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging counterpart of postural instability and vertical ocular dysfunction in patients with PSP: A multimodal MRI study.
    Quattrone A; Caligiuri ME; Morelli M; Nigro S; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Vaccaro MG; Sabatini U; Vescio V; Stanà C; Rocca F; Caracciolo M; Quattrone A
    Parkinsonism Relat Disord; 2019 Jun; 63():124-130. PubMed ID: 30803901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.